The Estimated Direct Medical Cost of Selected Sexually Transmitted Infections in the United States, 2008
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Millions of cases of sexually transmitted infections (STIs) occur in the United States each year, resulting in substantial medical costs to the nation. Previous estimates of the total direct cost of STIs are quite dated. We present updated direct medical cost estimates of STIs in the United States. METHODS: We assembled recent (i.e., 2002-2011) cost estimates to determine the lifetime cost per case of 8 major STIs (chlamydia, gonorrhea, hepatitis B virus, human immunodeficiency virus (HIV), human papillomavirus, genital herpes simplex virus type 2, trichomoniasis and syphilis). The total direct cost for each STI was computed as the product of the number of new or newly diagnosed cases in 2008 and the estimated discounted lifetime cost per case. All costs were adjusted to 2010 US dollars. RESULTS: Results indicated that the total lifetime direct medical cost of the 19.7 million cases of STIs that occurred among persons of all ages in 2008 in the United States was $15.6 (range, $11.0-$20.6) billion. Total costs were as follows: chlamydia ($516.7 [$258.3-$775.0] million), gonorrhea ($162.1 [$81.1-$243.2] million), hepatitis B virus ($50.7 [$41.3-$55.6] million), HIV ($12.6 [$9.5-$15.7] billion), human papillomavirus ($1.7 [$0.8-$2.9] billion), herpes simplex virus type 2 ($540.7 [$270.3-$811.0] million), syphilis ($39.3 [$19.6-$58.9] million), and trichomoniasis ($24.0 [$12.0-$36.0] million). Costs associated with HIV infection accounted for more than 81% of the total cost. Among the nonviral STIs, chlamydia was the most costly infection. CONCLUSIONS: Sexually transmitted infections continue to impose a substantial cost burden on the payers of medical care in the United States. The burden of STIs would be even greater in the absence of STI prevention and control efforts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For females, the cost per STI case ranges from $247 for Human Papilloma Virus (HPV) to $804 for Herpes-Simples Virus (HSV2).”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
In the citing paper
“The average cost per case of syphilis is $918 (either gender).”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
In the citing paper
“For males, the cost per case ranges from $39 for Chlamydia to $985 for HSV2.”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
Citations
Cites
Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq243 · Cited by 1,893 · cited 1×
“However, this estimate is applicable when considering the best-case scenario of HIV care in the United States, implying that applying their estimate could overestimate the total direct cost of HIV, because not all patients with HIV receive care and not all those who receive care get the best care available.(25,26) Hut…”
BackgroundSexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Su, J., Xu, F., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318286bb53 · Cited by 1,260
Self-citationSexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3600604 · Cited by 1,258
Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1111/j.1931-2393.2004.tb00002.x · Cited by 1,153
Estimated HIV Incidence in the United States, 2006–2009
Prejean, J., Song, R., Hernandez, A., Ziebell, R., Green, T., Walker, F., Lin, L. S., An, Q., Mermin, J., Lansky, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017502 · Cited by 1,071 · cited 1×
“For instance, in the past few years, the reported annual incidence of chlamydia, syphilis, and genital warts has increased,(6) although the annual incidence of gonorrhea and HIV infection has been relatively stable.(6,7) In addition, given the rapid changes in health care technology and service delivery, the lifetime…”
BackgroundRisk of Sequelae after Chlamydia trachomatis Genital Infection in Women
Haggerty, C. L., Gottlieb, S. L., Taylor, B. D., Low, N., Xu, F., & Ness, R. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/652395 · Cited by 657 · cited 1×
“5% of treated asymptomatic cases in women, with no PID assumed to develop in treated women with symptomatic chlamydia.(15) We assumed epididymitis developed in 1.”
BackgroundThe Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000
Chesson, H. W., Blandford, J. M., Gift, T. L., Tao, G., & Irwin, K. L. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3601104 · Cited by 444 · cited 8×
“Screening costs for asymptomatic persons were not included; in our previous estimate, these costs were included as part of the overall burden of chlamydia for persons infected with chlamydia.(1) We used previously published estimates of diagnosis and treatment costs for patients diagnosed in private physician/ health…”
BackgroundMethodResultInfluentialSelf-citationDevelopment and Duration of Human Papillomavirus Lesions, after Initial Infection
Winer, R. L., Kiviat, N. B., Hughes, J. P., Adam, D. E., Lee, S., Kuypers, J. M., & Koutsky, L. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427557 · Cited by 417
The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States
Schackman, B. R., Gebo, K. A., Walensky, R. P., Losina, E., Muccio, T., Sax, P. E., Weinstein, M. C., Seage, G. R., Moore, R. D., & Freedberg, K. A. (2006) · Medical Care · doi:10.1097/01.mlr.0000228021.89490.2a · Cited by 410 · cited 5×
“We reviewed 2 recent studies that estimated the direct lifetime cost of HIV infection in the United States (Schackman et al.(23) and Hutchinson et al.”
BackgroundMethodInfluentialHs, M. (1995) · JAMA · doi:10.1001/jama.274.15.1201 · Cited by 323 · cited 1×
“For example, the potential costs of liver transplantation were included in the 3 source studies cited earlier, whereas liver transplantation costs were not reflected in our original estimate.(1,22)”
Background
Cited by
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Papp, J. R., Schachter, J., Gaydos, C. A., & Pol, B. J. V. D. (2014) · PubMed · Cited by 823
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ771 · Cited by 588
Lifetime Economic Burden of Intimate Partner Violence Among U.S. Adults
Peterson, C., Kearns, M. C., McIntosh, W. L., Estefan, L. F., Nicolaidis, C., McCollister, K. E., Gordon, A., & Florence, C. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.049 · Cited by 471
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health
Petrova, M. I., Lievens, E., Malik, S., Imholz, N., & Lebeer, S. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00081 · Cited by 523
Screening for Chlamydia and Gonorrhea: U.S. Preventive Services Task Force Recommendation Statement
LeFevre, M. L., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m14-1981 · Cited by 304
Sexually transmitted infections and female reproductive health
Van Gerwen, O. T., Muzny, C. A., & Marrazzo, J. M. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01177-x · Cited by 224
Lifetime Economic Burden of Rape Among U.S. Adults
Peterson, C., DeGue, S., Florence, C., & Lokey, C. N. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.11.014 · Cited by 224
Sutton, M. Y., Lasswell, S. M., Lanier, Y., & Miller, K. S. (2014) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2013.11.004 · Cited by 183
Boda, D., Docea, A., Calina, D., Ilie, M., Caruntu, C., Zurac, S., Neagu, M., Constantin, C., Branisteanu, D., Voiculescu, V., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4256 · Cited by 176
“8x106 a year were among men and women aged 15 to 24 years, which in many cases were not clinically evident, accounting for most of both prevalent and incident infections (48,51).”
Meites, E., Gaydos, C. A., Hobbs, M. M., Kissinger, P., Nyirjesy, P., Schwebke, J. R., Secor, W. E., Sobel, J. D., & Workowski, K. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ738 · Cited by 167
Kreisel, K. M., Torrone, E., Bernstein, K. T., Hong, J., & Gorwitz, R. J. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6603a3 · Cited by 172
Toward global prevention of sexually transmitted infections (STIs): The need for STI vaccines
Gottlieb, S. L., Low, N., Newman, L. M., Bolan, G., Kamb, M., & Broutet, N. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.07.087 · Cited by 162
Status of vaccine research and development of vaccines for herpes simplex virus
Johnston, C., Gottlieb, S. L., & Wald, A. (2016) · Vaccine · doi:10.1016/j.vaccine.2015.12.076 · Cited by 166
“In the United States, HSV-2 infection is estimated to have a total lifetime cost of $540 million US dollars (adjusted to 2010 dollars), behind only HIV and HPV in costs among 8 major STIs [17 .”
Menezes, C. B., Frasson, A. P., & Tasca, T. (2016) · Microbial Cell · doi:10.15698/mic2016.09.526 · Cited by 185
“As a consequence of this overlooking, high costs and healthcare burden associated to trichomoniasis account to $24 million per year in the United States [56].”
Jones, C. M., Paulozzi, L. J., & Mack, K. A. (2014) · PubMed Central · Cited by 182
Resurgence of Syphilis in the United States: An Assessment of Contributing Factors
Schmidt, R., Carson, P. J., & Jansen, R. J. (2019) · Infectious Diseases Research and Treatment · doi:10.1177/1178633719883282 · Cited by 170
Kirkcaldy, R. D., Weinstock, H., Moore, P. C., Philip, S., Wiesenfeld, H. C., Papp, J. R., Kerndt, P. R., Johnson, S. M., Ghanem, K. G., Hook, E. W., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu521 · Cited by 162
Neglected Parasitic Infections in the United States: Trichomoniasis
Secor, W. E., Meites, E., Starr, M. C., & Workowski, K. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0723 · Cited by 140
Chesson, H. W., Spicknall, I. H., Bingham, A., Brisson, M., Eppink, S. T., Farnham, P. G., Kreisel, K. M., Kumar, S., Laprise, J., Peterman, T. A., et al. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001380 · Cited by 143
Self-citationPoint of care diagnostics for sexually transmitted infections: perspectives and advances
Gaydos, C., & Hardick, J. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.880651 · Cited by 117
Burke, P. J., Coles, M. S., Meglio, G. D., Gibson, E. J., Handschin, S., Lau, M., Marcell, A. V., Tebb, K., & Urbach, K. H. (2014) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2014.01.010 · Cited by 138
Edwards, J. L., Jennings, M. P., Apicella, M. A., & Seib, K. L. (2016) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1105782 · Cited by 135
Hadfield, J., Harris, S. R., Seth-Smith, H. M. B., Parmar, S., Andersson, P., Giffard, P. M., Schachter, J., Moncada, J., Ellison, L., Vaulet, M. L. G., et al. (2017) · Genome Research · doi:10.1101/gr.212647.116 · Cited by 123
Challenges of infectious diseases in the USA
KHABBAZ, R. F., Moseley, R. R., Steiner, R. J., Levitt, A. M., & Bell, B. P. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60890-4 · Cited by 117
Frost, J. J., Sonfield, A., Zolna, M. R., & Finer, L. B. (2014) · Milbank Quarterly · doi:10.1111/1468-0009.12080 · Cited by 129
Łaniewski, P., Cui, H., Roe, D. J., Barnes, D., Goulder, A., Monk, B. J., Greenspan, D. L., Chase, D. M., & Herbst‐Kralovetz, M. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-43849-5 · Cited by 118
Friedman, A. L., Kachur, R. E., Noar, S. M., & McFarlane, M. (2015) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000286 · Cited by 121
“Sexually transmitted diseases (STDs) are a serious public health problem in the United States, with more than 20 million cases each year,(1) costing the nation more than $16 billion in medical costs.(2) A lack of information, misperceptions about STDs, and biological and social influences can place individuals at risk…”
BackgroundConstantine, N. A., Jerman, P., Berglas, N. F., Angulo-Olaiz, F., Chou, C., & Rohrbach, L. A. (2015) · BMC Public Health · doi:10.1186/s12889-015-1625-5 · Cited by 109
Gottlieb, S. L., Ndowa, F. J., Hook, E. W., Deal, C. D., Bachmann, L. H., Abu-Raddad, L. J., Chen, X., Jerse, A. E., Low, N. N., MacLennan, C. A., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.02.073 · Cited by 94
Human Papillomavirus Infection and Vaccination
Valentino, K., & Poronsky, C. B. (2015) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2015.10.005 · Cited by 92
Maria, D. S., Guilamo‐Ramos, V., Jemmott, L. S., Derouin, A. L., & Villarruel, A. M. (2016) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000511566.12446.45 · Cited by 103
Redmond, S. M. S., Kislig, K., Woodhall, S. C., van den Broek, I. V. F., van Bergen, J. E. A. M., Ward, H., Uusküla, A., HERRMANN, B. F., Andersen, B. S., Götz, H. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115753 · Cited by 82
Oldfield, L. M., Grzesik, P., Voorhies, A. A., Alperovich, N., MacMath, D., Najera, C. D., Chandra, D. S., Prasad, S., Noskov, V. N., Montague, M. G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700534114 · Cited by 84
Bialkowski, L., van Weijnen, A., Van der Jeught, K., Renmans, D., Daszkiewicz, L., Heirman, C., Stangé, G., Breckpot, K., Aerts, J. L., & Thielemans, K. (2016) · Scientific Reports · doi:10.1038/srep22509 · Cited by 79
Chlamydial Antibiotic Resistance and Treatment Failure in Veterinary and Human Medicine
Borel, N., Leonard, C. A., Slade, J. A., & Schoborg, R. V. (2016) · Current Clinical Microbiology Reports · doi:10.1007/s40588-016-0028-4 · Cited by 80
Looker, K., Booton, R. D., Begum, N., Beck, E., Shen, J., Turner, K., & Christensen, H. (2023) · BMC Public Health · doi:10.1186/s12889-022-14670-z · Cited by 62
“…in 2018 [36], which were taken to equal gonorrhoea incidence in heterosexual women and men (“calibration data”) after first adjusting for the number of diagnoses in MSM [36], and adjusting for the fact that not all infections are diagnosed [14, 15, 17, 18, 40] (Table S2, Supplementary material).”
Interventions to Improve Sexually Transmitted Disease Screening in Clinic-Based Settings
Taylor, M. M., Frasure-Williams, J., Burnett, P., & Park, I. U. (2015) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000294 · Cited by 77
“6 billion dollars in lifetime direct medical costs per year.(1) Bacterial STDs including chlamydia (CT), gonorrhea (GC), From the *Division of STD Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA; †Arizona Department of Health Services, STD Program, Phoenix, AZ; ‡STD Control Branch, Division o…”
BackgroundVaginal microbiota and viral sexually transmitted diseases.
Nardis, C., Mosca, L., & Mastromarino, P. (2013) · PubMed · doi:10.7416/ai.2013.1946 · Cited by 76
“The analysis evidenced that costs associated with HIV infection accounted for more than 81% of the total cost (14).”
BackgroundStatus of vaccine research and development of vaccines for Chlamydia trachomatis infection
Poston, T. B., Gottlieb, S. L., & Darville, T. L. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.01.023 · Cited by 87
Liang, C., Bai, Y., Hsu, J.-W., Huang, K., Ko, N., Chu, H., Yeh, T., Tsai, S., Chen, T., & Chen, M. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz126 · Cited by 76
An increase in sexually transmitted infections seen in US emergency departments
Pearson, W. S., Peterman, T. A., & Gift, T. L. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.04.028 · Cited by 75
Self-citationCurrent status and prospects for development of an HSV vaccine
Johnston, C., Koelle, D. M., & Wald, A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.066 · Cited by 81
Sexually Transmitted Infections: Impact and Cost-Effectiveness of Prevention
Chesson, H. W., Mayaud, P., & Aral, S. O. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0524-0_ch10 · Cited by 95
Self-citationSaka, H. A., Thompson, J. W., Chen, Y.-S., Dubois, L. G., Haas, J. T., Moseley, M. A., & Valdivia, R. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124630 · Cited by 72
“trachomatis have reached costs as high as half a billion dollars annually [4].”
BackgroundThurgar, E., Barton, S., Karner, C., & Edwards, S. J. (2016) · Health Technology Assessment · doi:10.3310/hta20240 · Cited by 72
Impulsivity Dimensions and Risky Sex Behaviors in an At-Risk Young Adult Sample
Curry, I., Luk, J. W., Trim, R. S., Hopfer, C., Hewitt, J., Stallings, M., Brown, S. A., & Wall, T. (2017) · Archives of Sexual Behavior · doi:10.1007/s10508-017-1054-x · Cited by 59
“S.,directmedical services related to STDs cost $15.6 billion dollars each year (Owusu-Edusei et al., 2013).”
InfluentialShin, D. J., Athamanolap, P., Chen, L., Hardick, J. P., Lewis, M., Hsieh, Y., Rothman, R. E., Gaydos, C. A., & Wang, T. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-04781-8 · Cited by 68
Hall, W. J., Jones, B. L. H., Witkemper, K. D., Collins, T. L., & Rodgers, G. K. (2019) · American Journal of Health Behavior · doi:10.5993/ajhb.43.3.6 · Cited by 74
Pelvic inflammatory disease in the adolescent and young adult: An update
Greydanus, D. E., Cabral, M. D., & Patel, D. R. (2021) · Disease-a-Month · doi:10.1016/j.disamonth.2021.101287 · Cited by 71
Chen, A., & Dowdy, D. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108742 · Cited by 71
The societal cost of heroin use disorder in the United States
Jiang, R., Lee, I.-Y., Lee, T. A., & Pickard, A. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177323 · Cited by 69
Jean, S., Juneau, R. A., Criss, A. K., & Cornelissen, C. N. (2016) · Infection and Immunity · doi:10.1128/iai.00319-16 · Cited by 63
“2 million (2), representing a significant economic burden.”
BackgroundPrevention of injury and violence in the USA
Haegerich, T. M., Dahlberg, L. L., Simon, T. R., Baldwin, G. T., Sleet, D. A., Greenspan, A. I., & Degutis, L. C. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60074-x · Cited by 68
Russell, A. N., Zheng, X., O’Connell, C. M., Wiesenfeld, H. C., Hillier, S. L., Taylor, B. D., Picard, M. D., Flechtner, J. B., Zhong, W., Frazer, L. C., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw485 · Cited by 60
Palar, K., Laraia, B. A., Tsai, A. C., Johnson, M. O., & Weiser, S. D. (2016) · AIDS · doi:10.1097/qad.0000000000001095 · Cited by 61
Oliver, S. E., Hoots, B., Paz‐Bailey, G., Markowitz, L. E., Meites, E., & for the NHBS Study Group (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001413 · Cited by 58
Odegard, J., Flynn, P., Campbell, D. J., Robbins, S. H., Dong, L., Wang, K., ter Meulen, J., Cohen, J. I., & Koelle, D. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.137 · Cited by 56
Luo, L., He, P., Qiao-tu, L., Jiang, Y.-H., Zhang, Y.-N., Li, Q., Li, Q., Li, S.-T., Yang, F., Ling, H., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06019-5 · Cited by 54
Dize, L., Barnes, P., Barnes, M., Hsieh, Y., Marsiglia, V. C., Duncan, D., Hardick, J. P., & Gaydos, C. A. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.07.018 · Cited by 53
“Sexually transmitted infections (STIs) are a significant health burden in the United States which cost $10–17 billion annually due to a prevalence of 110 million cases including 19 million new cases per year (Owusu-Edusei et al., 2013; Satterwhite et al., 2013).”
Preston, S. M., & Darrow, W. W. (2019) · American Journal of Men s Health · doi:10.1177/1557988319883776 · Cited by 53
Single-Inclusion Kinetics of Chlamydia trachomatis Development
Chiarelli, T. J., Grieshaber, N. A., Omsland, A., Remien, C. H., & Grieshaber, S. S. (2020) · mSystems · doi:10.1128/msystems.00689-20 · Cited by 52
“According to the CDC, C. trachomatis is the most frequently reported sexually transmitted infection in the United States, costing the American health care system nearly $2.4 billion annually (3, 4).”
InfluentialExperimentally Induced Endometritis Impairs the Developmental Capacity of Bovine Oocytes†
Dickson, M. J., Piersanti, R. L., Ramírez-Hernández, R., de Oliveira, E. B., Bishop, J. V., Hansen, T. R., Ma, Z., Jeong, K. C., Santos, J. E. P., Sheldon, I. M., et al. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa069 · Cited by 52
Human papillomavirus and cervical cancer
Ansari, F. (2020) · Port Harcourt Medical Journal · doi:10.4103/phmj.phmj_2_20 · Cited by 51
Continuing Need for Sexually Transmitted Disease Clinics After the Affordable Care Act
Hoover, K. W., Parsell, B. W., Leichliter, J. S., Habel, M. A., Tao, G., Pearson, W. S., & Gift, T. L. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302839 · Cited by 51
Self-citationSexual discounting: A systematic review of discounting processes and sexual behavior.
Johnson, M. W., Strickland, J. C., Herrmann, E. S., Dolan, S. B., Cox, D. J., & Berry, M. S. (2021) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000402 · Cited by 53
HPV strain distribution in patients with genital warts in a female population sample
Boda, D., Neagu, M. T., Constantin, C., Voinescu, R. N., Căruntu, C., Zurac, S., Spandidos, D. A., Drakoulis, N., Tsoukalas, D., & Tsatsakis, A. M. (2016) · Oncology Letters · doi:10.3892/ol.2016.4903 · Cited by 49
“In this context, in 2013, two analyses developed under the aegis of the Center for Disease and Control and Prevention (CDC) highlighted the severe human and economic burden associated with sexually transmitted infections (STIs) in the United States (6,7).”
Meites, E. (2013) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2013.06.003 · Cited by 53
Immunity against a Chlamydia infection and disease may be determined by a balance of IL‐17 signaling
O’Meara, C. P., Armitage, C. W., Harvie, M., Andrew, D. W., Timms, P., Lycke, N. Y., & Beagley, K. W. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.92 · Cited by 48
Grulich, A. E., de Visser, R. O., Badcock, P. B., Smith, A. M. A., Richters, J., Rissel, C. E., & Simpson, J. M. (2014) · Sexual Health · doi:10.1071/sh14121 · Cited by 51
Neutrophils Are Central to Antibody-Mediated Protection against Genital Chlamydia
Naglak, E. K., Morrison, S. G., & Morrison, R. P. (2017) · Infection and Immunity · doi:10.1128/iai.00409-17 · Cited by 48
Gottlieb, S. L., Giersing, B. K., Boily, M., Chesson, H. W., Looker, K. J., Schiffer, J. T., Spicknall, I. H., Hutubessy, R. C. W., & Broutet, N. J. N. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.074 · Cited by 46
Self-citationOlsen, A. W., Lorenzen, E., Rosenkrands, I., Follmann, F., & Andersen, P. L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01652 · Cited by 46
Maurakis, S., Keller, K., Maxwell, C. N., Pereira, K., Chazin, W. J., Criss, A. K., & Cornelissen, C. N. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007937 · Cited by 45
Monetary conversion factors for economic evaluations of substance use disorders
McCollister, K., Yang, X., Sayed, B., French, M. T., Leff, J. A., & Schackman, B. R. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.07.008 · Cited by 43
Liang, P., Rosas‐Lemus, M., Patel, D. B., Fang, X., Tuz, K., & Juárez, O. X. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.797209 · Cited by 43
“trachomatis infections have a high impact on public health with a yearly expenditure of more than $500 million in direct medical costs, by the American health care system alone (7).”
BackgroundCost-effectiveness of Chlamydia Vaccination Programs for Young Women
Owusu‐Edusei, K., Chesson, H. W., Gift, T. L., Brunham, R. C., & BOLAN, G. A. (2015) · Emerging infectious diseases · doi:10.3201/eid2106.141270 · Cited by 42
“8 million cases of chlamydia among all persons of all ages in 2008 (3) and that the estimated direct lifetime cost was >$500 million 2013 US dollars (4).”
Self-citationChallenges and Persistent Questions in the Treatment of Trichomoniasis
Vieira, P., Tasca, T., & Secor, W. E. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160930150429 · Cited by 42
Spicknall, I. H., Mayer, K. H., Aral, S. O., & Romero-Severson, E. O. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000953 · Cited by 40
Kumar, S., Chesson, H. W., Spicknall, I. H., Kreisel, K. M., & Gift, T. L. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001357 · Cited by 40
Self-citationRégnier, S. A., & Huels, J. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.36221 · Cited by 40
Carleton, P. F., Schachter, S. C., Parrish, J. A., Collins, J. M., Crocker, J. B., Dixon, R. F., Edgman‐Levitan, S., Lewandrowski, K. B., Stahl, J. E., Klapperich, C. M., et al. (2016) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2016.2598837 · Cited by 38
Estimates of the Prevalence and Incidence of Genital Herpes, United States, 2018
Spicknall, I. H., Flagg, E. W., & Torrone, E. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001375 · Cited by 38
STI Prevalence, Incidence, and Costs in the United States: New Estimates, New Approach
Weinstock, H., Kreisel, K. M., Spicknall, I. H., Chesson, H. W., & Miller, W. C. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001368 · Cited by 41
Self-citationTuite, A. R., Burchell, A. N., & Fisman, D. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101240 · Cited by 38
Chang, B. A., Pearson, W. S., & Owusu‐Edusei, K. (2017) · Annals of Epidemiology · doi:10.1016/j.annepidem.2017.02.004 · Cited by 37
Self-citationSubunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis
Yu, H. B., Karunakaran, K. P., Jiang, X., & Brunham, R. C. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1161510 · Cited by 36
Bernstein, D. I., Cardin, R. D., Bravo, F., Hamouda, T., Pullum, D. A., Cohen, G. H., Bitko, V., & Fattom, A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.08.077 · Cited by 36
“Further, in the United States, HSV-2 contributes an estimated $540 million total lifetime costs to the national healthcare system [16] even when the costs associated with neonatal infections and the role of HSV-2 in promoting the acquisition of HIV are not included.”
BackgroundWray, T. B., Simons, J. S., & Maisto, S. A. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.10.037 · Cited by 37
Silva, S., Ayoub, H. H., Johnston, C., Atun, R. A., & Abu-Raddad, L. J. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003938 · Cited by 35
Leichliter, J. S., Chandra, A., & Aral, S. O. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318285ce46 · Cited by 35
Rigo, G. V., Petró-Silveira, B., Devereux, M. M., McCann, M., dos Santos, A. L. S., & Tasca, T. (2018) · Parasitology · doi:10.1017/s003118201800152x · Cited by 35
“The elevated prevalence of infection has been linked to scarce STI control programmes, and the annual cost to the public health bill in the USA alone to treat trichomoniasis and its associated complications has been estimated to be US$24–167 million (Owusu-Edusei et al., 2013).”
BackgroundLewis, F. M. T., Spicknall, I. H., Flagg, E. W., Papp, J. R., & Kreisel, K. M. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001383 · Cited by 33
Tayoun, A. N. A., Burchard, P. R., Caliendo, A. M., Scherer, A., & Tsongalis, G. J. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.01.011 · Cited by 36
“…and accuracy, with rapid turnaround times, making for a more appealing alternative to culture-based testing methods which are often limited by long culture times and low sensitivity with certain sample types (Espy et al., 2006; Palavecino, 2014; Braverman et al., 2002; Battle et al., 2001).”
BackgroundCDC Grand Rounds: global tobacco control.
Asma, S., Song, Y., Cohen, J. E., Eriksen, M. P., Pechacek, T. F., Cohen, N. J., & Iskander, J. K. (2014) · PubMed Central · Cited by 34
Dean, H. D., & Fenton, K. A. (2013) · Public Health Reports · doi:10.1177/00333549131286s302 · Cited by 34
Li, Y., You, S., Lee, K., Yaesoubi, R., Hsu, K., Gift, T. L., Chesson, H. W., Berruti, A. A., Salomon, J. A., & Rönn, M. M. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad047 · Cited by 33
Self-citationJozkowski, K. N., & Crawford, B. L. (2015) · Sexuality Research and Social Policy · doi:10.1007/s13178-015-0208-7 · Cited by 33
The ABCs of STIs: An Update on Sexually Transmitted Infections
Yarbrough, M. L., & Burnham, C. D. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.240234 · Cited by 37
Using Facebook™ to Recruit College-Age Men for a Human Papillomavirus Vaccine Trial
Raviotta, J. M., Nowalk, M. P., Lin, C. J., Huang, H.-H., & Zimmerman, R. K. (2014) · American Journal of Men s Health · doi:10.1177/1557988314557563 · Cited by 33
“Annually, the cost of treating cervical intraepithelial neoplasia, head and neck malignancies, recurrent respiratory papillomatosis, and genital warts exceeds $1.7 billion (Owusu-Edusei et al., 2013).”
BackgroundInfluential
Metadata
- Authors
- Owusu-Edusei, K., Chesson, H. W., Gift, T. L., Tao, G., Mahajan, R., Ocfemia, M. C. B., & Kent, C. K.
- Corresponding author
- Chesson, Harrell W.
- Gift, Thomas L.
- Tao, Guoyu
- Kent, Charlotte K.
- Venue
- Sexually Transmitted Diseases
- Published
- 2013-03
- Volume
- 40
- Issue
- 3
- Pages
- 197-201
- ISSN
- 0148-5717 (ISSN-L)
- OpenAlex
- W2064915358
- Cited by
- 452
- References
- 32
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 9 · 2023: 20 · 2022: 21 · 2021: 37 · 2020: 39 · 2019: 39 · 2018: 45 · 2017: 75 · 2016: 41 · 2015: 46 · 2014: 53 · 2013: 17
- FWCI
- 47.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Sexually Transmitted Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- sexually transmitted infections, direct medical costs, HIV, chlamydia, gonorrhea, hepatitis B virus, human papillomavirus, herpes simplex virus type 2, syphilis, trichomoniasis, cost burden
- MeSH terms
- Chlamydia Infections, Condylomata Acuminata, Female, Gonorrhea, Hepatitis B, Herpes Genitalis, Humans, Male, Sexually Transmitted Diseases, Syphilis, Trichomonas Infections, United States, HIV Infections, Health Care Costs, Cost of Illness, Models, Economic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.